LOGIN  |  REGISTER
Recursion

Recent Insider Transactions - DiaMedica Therapeutics (NASDAQ: DMAC)

Follow NASDAQ:DMAC Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ DMAC DiaMedica Therapeutics
Wambeke David J. / officer: Chief Business Officer
06/01/2025
Buy
$4.11
250,000
$1.028M
250,000
NASDAQ DMAC DiaMedica Therapeutics
Semba Charles Pauling / director
06/01/2025
Buy
$4.11
32,162
$132K
32,162
NASDAQ DMAC DiaMedica Therapeutics
Pauls Dietrich John / director, officer: President & CEO
06/01/2025
Buy
$4.11
600,000
$2.466M
600,000
NASDAQ DMAC DiaMedica Therapeutics
Parsons James T. / director
06/01/2025
Buy
$4.11
40,739
$167K
40,739
NASDAQ DMAC DiaMedica Therapeutics
Lewis Tanya / director
06/01/2025
Buy
$4.11
32,162
$132K
32,162
NASDAQ DMAC DiaMedica Therapeutics
Kuntz Richard / director
06/01/2025
Buy
$4.11
32,162
$132K
32,162
NASDAQ DMAC DiaMedica Therapeutics
Kellen Scott / officer: CFO & Secretary
06/01/2025
Buy
$4.11
225,000
$925K
225,000
NASDAQ DMAC DiaMedica Therapeutics
Giuffre Randall Michael / director
06/01/2025
Buy
$4.11
32,162
$132K
32,162

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous